Compare Agnico Eagle Mines Ltd (AEM) vs Novo Nordisk A/S (NVO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Agnico Eagle Mines Ltd vs Novo Nordisk A/S — how do they compare? Agnico Eagle Mines Ltd trades at $184.09 (market cap $92.01B), while Novo Nordisk A/S trades at $45.97 (market cap $207.85B). The key difference: Novo Nordisk A/S is far larger — about 2.3× Agnico Eagle Mines Ltd's market cap, and Novo Nordisk A/S pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| AEM | NVO | |
|---|---|---|
Market Cap | $92.01B | $207.85B |
Sector | Basic Materials | Health |
52-Week High | $252.19 | $63.98 |
52-Week Low | $130.23 | $35.29 |
Enterprise Value | $88.85B | $222.55B |
Dividend Yield | 0.99% | 3.81% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Agnico Eagle Mines Ltd
Agnico Eagle Mines is a gold miner operating mines in Canada, Mexico, and Finland. It also owns 50% of the Canadian Malartic mine. Agnico operated just one mine, LaRonde, as recently as 2008 before bringing its other mines on line in rapid succession in the following years. The company produced more than 1.7 million gold ounces in 2020. Agnico Eagle is focused on increasing gold production in lower-risk jurisdictions.
Read more on AEM →About Novo Nordisk A/S
With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.
Read more on NVO →
